Cargando…

Expression Analysis of SOCS Genes in Migraine

Migraine is a complex neurological condition affecting a large proportion of persons. Dysregulation of several immune-related transcripts has been noted in migraineurs suggesting an immune-based background for this condition. We measured expression levels suppressor of cytokine signaling (SOCS) gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghafouri-Fard, Soudeh, Honarmand Tamizkar, Kasra, Sayad, Arezou, Taheri, Mohammad, Samadian, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502924/
https://www.ncbi.nlm.nih.gov/pubmed/34646121
http://dx.doi.org/10.3389/fnmol.2021.725048
_version_ 1784580998452740096
author Ghafouri-Fard, Soudeh
Honarmand Tamizkar, Kasra
Sayad, Arezou
Taheri, Mohammad
Samadian, Mohammad
author_facet Ghafouri-Fard, Soudeh
Honarmand Tamizkar, Kasra
Sayad, Arezou
Taheri, Mohammad
Samadian, Mohammad
author_sort Ghafouri-Fard, Soudeh
collection PubMed
description Migraine is a complex neurological condition affecting a large proportion of persons. Dysregulation of several immune-related transcripts has been noted in migraineurs suggesting an immune-based background for this condition. We measured expression levels suppressor of cytokine signaling (SOCS) genes in the venous blood of migraineurs compared with controls. SOCS1 was down-regulated in patients without aura compared with controls [Ratio of mean expression (RME) = 0.08, P value < 0.001]. This pattern was also detected among female subgroups (RME = 0.06, P value = 0.010), but not among male subgroups (RME = 0.22, P value = 0.114). Expression of SOCS1 was significantly higher in patients with aura compared with those without aura (RME = 5.89, P value = 0.037). Meanwhile, expression of SOCS2 was lower in migraineurs with aura compared with controls (RME = 0.03, P value < 0.001). In addition, this gene was under-expressed in patients without aura compared with controls and in both sex-based subgroups of this group of patients (RME = 0.01, P value < 0.001 for all comparisons). However, its expression was higher in male patients with aura compared with those without aura (P value < 0.001). For SOCS3, we detected a lower level of expression in patients without aura compared with controls (RME = 0.07, P value < 0.001). However, the expression of SOCS3 was higher in patients with aura compared with those without aura (RME = 7.46, P value = 0.001). SOCS5 was down-regulated in patients without aura compared with controls (RME = 0.10, P value < 0.001). Expression of this gene was also lower in patients with aura compared with controls (RME = 0.03, P value < 0.001), and in male patients of this group compared with controls (RME = 0.03, P value = 0.004). On the other hand, expression of SOCS5 was higher in male patients with aura compared with sex-matched patients without aura (RME = 6.67, P value = 0.001). SOCS2 levels could appropriately differentiate migraineurs from healthy subjects. The current study suggests the role of SOCS genes in the pathoetiology of migraine.
format Online
Article
Text
id pubmed-8502924
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85029242021-10-12 Expression Analysis of SOCS Genes in Migraine Ghafouri-Fard, Soudeh Honarmand Tamizkar, Kasra Sayad, Arezou Taheri, Mohammad Samadian, Mohammad Front Mol Neurosci Molecular Neuroscience Migraine is a complex neurological condition affecting a large proportion of persons. Dysregulation of several immune-related transcripts has been noted in migraineurs suggesting an immune-based background for this condition. We measured expression levels suppressor of cytokine signaling (SOCS) genes in the venous blood of migraineurs compared with controls. SOCS1 was down-regulated in patients without aura compared with controls [Ratio of mean expression (RME) = 0.08, P value < 0.001]. This pattern was also detected among female subgroups (RME = 0.06, P value = 0.010), but not among male subgroups (RME = 0.22, P value = 0.114). Expression of SOCS1 was significantly higher in patients with aura compared with those without aura (RME = 5.89, P value = 0.037). Meanwhile, expression of SOCS2 was lower in migraineurs with aura compared with controls (RME = 0.03, P value < 0.001). In addition, this gene was under-expressed in patients without aura compared with controls and in both sex-based subgroups of this group of patients (RME = 0.01, P value < 0.001 for all comparisons). However, its expression was higher in male patients with aura compared with those without aura (P value < 0.001). For SOCS3, we detected a lower level of expression in patients without aura compared with controls (RME = 0.07, P value < 0.001). However, the expression of SOCS3 was higher in patients with aura compared with those without aura (RME = 7.46, P value = 0.001). SOCS5 was down-regulated in patients without aura compared with controls (RME = 0.10, P value < 0.001). Expression of this gene was also lower in patients with aura compared with controls (RME = 0.03, P value < 0.001), and in male patients of this group compared with controls (RME = 0.03, P value = 0.004). On the other hand, expression of SOCS5 was higher in male patients with aura compared with sex-matched patients without aura (RME = 6.67, P value = 0.001). SOCS2 levels could appropriately differentiate migraineurs from healthy subjects. The current study suggests the role of SOCS genes in the pathoetiology of migraine. Frontiers Media S.A. 2021-09-27 /pmc/articles/PMC8502924/ /pubmed/34646121 http://dx.doi.org/10.3389/fnmol.2021.725048 Text en Copyright © 2021 Ghafouri-Fard, Honarmand Tamizkar, Sayad, Taheri and Samadian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Ghafouri-Fard, Soudeh
Honarmand Tamizkar, Kasra
Sayad, Arezou
Taheri, Mohammad
Samadian, Mohammad
Expression Analysis of SOCS Genes in Migraine
title Expression Analysis of SOCS Genes in Migraine
title_full Expression Analysis of SOCS Genes in Migraine
title_fullStr Expression Analysis of SOCS Genes in Migraine
title_full_unstemmed Expression Analysis of SOCS Genes in Migraine
title_short Expression Analysis of SOCS Genes in Migraine
title_sort expression analysis of socs genes in migraine
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502924/
https://www.ncbi.nlm.nih.gov/pubmed/34646121
http://dx.doi.org/10.3389/fnmol.2021.725048
work_keys_str_mv AT ghafourifardsoudeh expressionanalysisofsocsgenesinmigraine
AT honarmandtamizkarkasra expressionanalysisofsocsgenesinmigraine
AT sayadarezou expressionanalysisofsocsgenesinmigraine
AT taherimohammad expressionanalysisofsocsgenesinmigraine
AT samadianmohammad expressionanalysisofsocsgenesinmigraine